Patents by Inventor Kurt D. Deshayes

Kurt D. Deshayes has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method of inhibiting insulin-like growth factor-1 (IGF-1) by IGF-1-antagonist peptides
    Patent number: 7432244
    Abstract: Peptides are provided that antagonize the interaction of IGF-1 with its binding proteins, insulin receptor, and IGF receptor. These IGF antagonist peptides are useful in treating disorders involving IGF-1 as a causative agent, such as, for example, various cancers.
    Type: Grant
    Filed: June 23, 2006
    Date of Patent: October 7, 2008
    Assignee: Genentech, Inc.
    Inventors: Kurt D. Deshayes, Henry B. Lowman, Michelle L. Schaffer, Sachdev S. Sidhu
  • IGF antagonist peptides
    Patent number: 7071300
    Abstract: Peptides are provided that antagonize the interaction of IGF-1 with its binding proteins, insulin receptor, and IGF receptor. These IGF antagonist peptides are useful in treating disorders involving IGF-1 as a causative agent, such as, for example, various cancers.
    Type: Grant
    Filed: March 13, 2002
    Date of Patent: July 4, 2006
    Assignee: Genentech, Inc.
    Inventors: Kurt D. Deshayes, Henry B. Lowman, Michelle L. Schaffer, Sachdev S. Sidhu
  • IGF antagonist peptides
    Publication number: 20030092631
    Abstract: Peptides are provided that antagonize the interaction of IGF-1 with its binding proteins, insulin receptor, and IGF receptor. These IGF antagonist peptides are useful in treating disorders involving IGF-1 as a causative agent, such as, for example, various cancers.
    Type: Application
    Filed: March 13, 2002
    Publication date: May 15, 2003
    Applicant: GENENTECH, INC.
    Inventors: Kurt D. Deshayes, Henry B. Lowman, Michelle L. Schaffer, Sachdev S. Sidhu